Astellas Pharma's market cap is currently ―. The company's EPS TTM is $-0.009; its P/E ratio is -1,038.04; and it has a dividend yield of 5.01%. Astellas Pharma is scheduled to report earnings on April 25, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21
Income Statement	-
Total Revenue	¥ 402.18B	-	¥ 381.79B	¥ 303.87B	¥ 340.63B
Gross Profit	¥ 327.76B	-	¥ 292.92B	¥ 244.96B	¥ 271.27B
EBIT	¥ 62.56B	-	¥ 34.08B	¥ -9.84B	¥ 79.62B
EBITDA	¥ 85.56B	-	¥ 70.95B	¥ 11.24B	¥ 101.14B
Net Income Common Stockholders	¥ 48.41B	-	¥ 24.81B	¥ -8.41B	¥ 60.88B
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	¥ 413.30B	¥ 0.00	¥ 336.76B	¥ 337.28B	¥ 368.09B
Total Assets	¥ 2.51T	-	¥ 2.48T	¥ 2.33T	¥ 2.36T
Total Debt	¥ 0.00	¥ 0.00	¥ 0.00	¥ 0.00	¥ 0.00
Net Debt	¥ -413.30B	¥ 0.00	¥ -336.76B	¥ -337.28B	¥ -368.09B
Total Liabilities	-	-	¥ 942.79B	¥ 872.09B	¥ 889.95B
Stockholders Equity	¥ 1.57T	¥ 0.00	¥ 1.54T	¥ 1.46T	¥ 1.47T
Cash Flow	-
Free Cash Flow	¥ 51.58B	-	¥ 30.57B	¥ 31.31B	¥ 58.17B
Operating Cash Flow	¥ 72.32B	-	¥ 48.83B	¥ 48.59B	¥ 69.47B
Investing Cash Flow	¥ -27.12B	-	¥ -19.14B	¥ -14.83B	¥ 8.16B
Financing Cash Flow	¥ -9.69B	-	¥ -46.60B	¥ -75.03B	¥ -51.33B

Currency in JPY

Astellas Pharma Earnings and Revenue History

Income Statement >

Astellas Pharma Debt to Assets

Balance Sheet >

Astellas Pharma Cash Flow

Cash Flow >

Astellas Pharma Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing